News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
46 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24222)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
Business
Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
Sigilon’s Afibromer technology will be used to encapsulate insulin-producing cells for the potential treatment of type 1 diabetes
April 4, 2018
·
6 min read
Business
Kymera Therapeutics Announces Discovery Collaboration with GSK to Advance New Treatment Modality
Collaboration to Accelerate the Discovery of Protein Degrading Therapeutics
April 4, 2018
·
3 min read
Deals
Inception Neuroscience Program Acquired by Roche
Another successful outcome from a Versant Discovery Engine Launching successor company, Pipeline Therapeutics
April 4, 2018
·
3 min read
Business
ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development
Collaboration will provide clients competitive advantages, improve speed to market
April 4, 2018
·
4 min read
Lone Star Bio
New Publication Highlights Significant Impact of DecisionDx-Melanoma Prognostic Test on Clinical Management of Patients with Melanoma
Prospective, multicenter study recently published in SKIN The Journal of Cutaneous Medicine
April 4, 2018
·
5 min read
Pharm Country
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Proceeds to advance lead oncology programs into the clinic and broaden early-stage pipeline
April 4, 2018
·
3 min read
Business
Medeor Therapeutics Expands Executive Team
Appointed Iqbal Husain, Ph.D., as its Senior Vice President, Program Management, and Michael Zdanowski as its Vice President, Biopharmaceutical Operations.
April 4, 2018
·
2 min read
Drug Development
Sangamo Announces Publication In Molecular Therapy Of Preclinical Study Data From MPS II In Vivo Genome Editing Program
Study provided proof of concept for development of SB-913 product candidate currently being evaluated in Phase 1/2 clinical trial.
April 4, 2018
·
7 min read
Business
NextCure Appoints Kevin N. Heller, M.D., as Chief Medical Officer and Steve Cobourn, CPA, as Chief Financial Officer
Both are accomplished executives with proven track records in building biopharmaceutical companies.
April 4, 2018
·
2 min read
Drug Development
Bioniz Therapeutics Initiates Phase 1/2 Clinical Study of BNZ‑1 in T-Cell Leukemia and Lymphoma
Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company developing first-in-class peptide therapeutics that selectively and simultaneously inhibit multiple cytokines to treat immuno-inflammatory diseases and T-cell malignancies, today announced that it has initiated a Phase 1/2 open-label clinical study of its lead product candidate BNZ-1
April 4, 2018
·
4 min read
1 of 5
Next
